BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11714776)

  • 1. The activatory receptor 2B4 is expressed in vivo by human CD8+ effector alpha beta T cells.
    Speiser DE; Colonna M; Ayyoub M; Cella M; Pittet MJ; Batard P; Valmori D; Guillaume P; Liénard D; Cerottini JC; Romero P
    J Immunol; 2001 Dec; 167(11):6165-70. PubMed ID: 11714776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
    Mortarini R; Piris A; Maurichi A; Molla A; Bersani I; Bono A; Bartoli C; Santinami M; Lombardo C; Ravagnani F; Cascinelli N; Parmiani G; Anichini A
    Cancer Res; 2003 May; 63(10):2535-45. PubMed ID: 12750277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional heterogeneity of cytokines and cytolytic effector molecules in human CD8+ T lymphocytes.
    Sandberg JK; Fast NM; Nixon DF
    J Immunol; 2001 Jul; 167(1):181-7. PubMed ID: 11418647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of CD8+ T cells from tumor-invaded and tumor-free lymph nodes of melanoma patients: role of common gamma-chain cytokines.
    Anichini A; Scarito A; Molla A; Parmiani G; Mortarini R
    J Immunol; 2003 Aug; 171(4):2134-41. PubMed ID: 12902520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases.
    Pittet MJ; Zippelius A; Speiser DE; Assenmacher M; Guillaume P; Valmori D; Liénard D; Lejeune F; Cerottini JC; Romero P
    J Immunol; 2001 Jun; 166(12):7634-40. PubMed ID: 11390521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three memory subsets of human CD8+ T cells differently expressing three cytolytic effector molecules.
    Takata H; Takiguchi M
    J Immunol; 2006 Oct; 177(7):4330-40. PubMed ID: 16982867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of MHC class-I restricted TCRalphabeta+ CD4- CD8- double negative T cells recognizing the gp100 antigen from a melanoma patient after gp100 vaccination.
    Voelkl S; Moore TV; Rehli M; Nishimura MI; Mackensen A; Fischer K
    Cancer Immunol Immunother; 2009 May; 58(5):709-18. PubMed ID: 18836718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-alpha results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursors.
    Di Pucchio T; Pilla L; Capone I; Ferrantini M; Montefiore E; Urbani F; Patuzzo R; Pennacchioli E; Santinami M; Cova A; Sovena G; Arienti F; Lombardo C; Lombardi A; Caporaso P; D'Atri S; Marchetti P; Bonmassar E; Parmiani G; Belardelli F; Rivoltini L
    Cancer Res; 2006 May; 66(9):4943-51. PubMed ID: 16651452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice.
    Johnson BJ; Costelloe EO; Fitzpatrick DR; Haanen JB; Schumacher TN; Brown LE; Kelso A
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2657-62. PubMed ID: 12601154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel approach to characterize clonality and differentiation of human melanoma-specific T cell responses: spontaneous priming and efficient boosting by vaccination.
    Speiser DE; Baumgaertner P; Barbey C; Rubio-Godoy V; Moulin A; Corthesy P; Devevre E; Dietrich PY; Rimoldi D; Liénard D; Cerottini JC; Romero P; Rufer N
    J Immunol; 2006 Jul; 177(2):1338-48. PubMed ID: 16818795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic and functional heterogeneity of EBV epitope-specific CD8+ T cells.
    Catalina MD; Sullivan JL; Brody RM; Luzuriaga K
    J Immunol; 2002 Apr; 168(8):4184-91. PubMed ID: 11937579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous coexpression of memory-related and effector-related genes by individual human CD8 T cells depends on antigen specificity and differentiation.
    Gupta B; Iancu EM; Gannon PO; Wieckowski S; Baitsch L; Speiser DE; Rufer N
    J Immunother; 2012 Jul; 35(6):488-501. PubMed ID: 22735807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with a Melan-A peptide selects an oligoclonal T cell population with increased functional avidity and tumor reactivity.
    Valmori D; Dutoit V; Schnuriger V; Quiquerez AL; Pittet MJ; Guillaume P; Rubio-Godoy V; Walker PR; Rimoldi D; Liénard D; Cerottini JC; Romero P; Dietrich PY
    J Immunol; 2002 Apr; 168(8):4231-40. PubMed ID: 11937585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate early effector functions of virus-specific CD8+CCR7+ memory cells in humans defined by HLA and CC chemokine ligand 19 tetramers.
    Ravkov EV; Myrick CM; Altman JD
    J Immunol; 2003 Mar; 170(5):2461-8. PubMed ID: 12594271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid high efficiency sensitization of CD8+ T cells to tumor antigens by dendritic cells leads to enhanced functional avidity and direct tumor recognition through an IL-12-dependent mechanism.
    Xu S; Koski GK; Faries M; Bedrosian I; Mick R; Maeurer M; Cheever MA; Cohen PA; Czerniecki BJ
    J Immunol; 2003 Sep; 171(5):2251-61. PubMed ID: 12928369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosensitization of melanoma tumor cells to non-MHC Fas-mediated killing by MART-1-specific CTL cultures.
    Frost PJ; Butterfield LH; Dissette VB; Economou JS; Bonavida B
    J Immunol; 2001 Mar; 166(5):3564-73. PubMed ID: 11207317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human tumor-derived heat shock protein 96 mediates in vitro activation and in vivo expansion of melanoma- and colon carcinoma-specific T cells.
    Rivoltini L; Castelli C; Carrabba M; Mazzaferro V; Pilla L; Huber V; Coppa J; Gallino G; Scheibenbogen C; Squarcina P; Cova A; Camerini R; Lewis JJ; Srivastava PK; Parmiani G
    J Immunol; 2003 Oct; 171(7):3467-74. PubMed ID: 14500642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of CXCR4 expression on human CD8+ T cells during peripheral differentiation.
    Kobayashi N; Takata H; Yokota S; Takiguchi M
    Eur J Immunol; 2004 Dec; 34(12):3370-8. PubMed ID: 15549771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of human granzymes A, B, and K in natural killer cells and during CD8+ T cell differentiation in peripheral blood.
    Bratke K; Kuepper M; Bade B; Virchow JC; Luttmann W
    Eur J Immunol; 2005 Sep; 35(9):2608-16. PubMed ID: 16106370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordant expression of perforin and granzyme A in total and HIV-specific CD8 T lymphocytes of HIV infected children and adolescents.
    Haridas V; McCloskey TW; Pahwa R; Pahwa S
    AIDS; 2003 Nov; 17(16):2313-22. PubMed ID: 14571182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.